Clinical Study
Treatment Challenges in Pediatric Stroke Patients
Table 4
Medication in prophylaxis.
| | Medication | Acute ischemic stroke n(%) | Sinovenous-thrombosis n(%) | Hemorrhagic stroke n(%) |
| | Aspirin | 7 (%7.5) | 2 (%25) | — | | LMWH | 6 (%6.5) | 1 (12.5) | — | | Warfarin | 1 (%1.1) | — | — |
|
|
low molecular weight heparin.
|
